Founded in 2017, Biorocks is a biotechnology company dedicated to advancing automation in cell and embryo manipulation.
Our technologies support applications across biomedicine, livestock breeding, and laboratory animal research, covering key processes such as cell selection, culture, vitrification, and warming. By combining automation, standardization, and high-throughput capabilities, we help laboratories and breeding programs improve efficiency, consistency, and scalability.
Biorocks has established a growing intellectual property portfolio comprising 120 patent applications and granted patents, including 19 invention patents and 43 PCT applications.
Embryo vitrification and warming have traditionally relied heavily on manual operation, making results highly dependent on operator experience. To address this challenge, Biorocks developed an automated, high-throughput embryo vitrification and warming platform based on proprietary microfluidic technology. The system reduces hands-on workload and operator-dependent variability while supporting more standardized and reproducible laboratory workflows.
Behind Biorocks' innovation is a multidisciplinary team of PhD and postdoctoral researchers from leading institutions in China and abroad, including Harvard University, Tsinghua University, and The Hong Kong University of Science and Technology. In addition to strong academic credentials, the team brings extensive practical experience in microfluidic technologies, high-end medical-device development, precision manufacturing, medical-device registration, and the development of global sales networks.
Biorocks has earned recognition from institutional investors and industry organizations for its technological innovation and commercial potential.
The company has completed five rounds of institutional investment, with investors including Lenovo Capital and Incubator Group, Shenzhen High-Tech Investment Group, Leaguer Group, and multiple rounds of investment from Zero2IPO Venture Capital.Biorocks has been recognized as a Specialized, Refined, Distinctive and Innovative SME and as an Innovative SME.
·Champion, HKUST One Million Dollar Entrepreneurship Competition
·Gold Award, 2022 Qianhai Guangdong–Hong Kong–Macao–Taiwan Youth Innovation and Entrepreneurship Competition
·Second Prize, 2024 China Shenzhen Innovation and Entrepreneurship Competition
·Selected for the 2023 Microsoft for Startups Accelerator
·Gold Award, 2025 Guangdong–Hong Kong–Macao Greater Bay Area Entrepreneurship Competition
·First Prize, Inner Mongolia Division, 2025 China Innovation and Entrepreneurship Competition